Modified protein selection strategy based on Escherichia coli’s Hitchhiker transport and validation through selection of nanobodies targeting bovine interferon gamma

1. Morioka, K., Fukai, K., Sakamoto, K., Yoshida, K. & Kanno, T. Evaluation of monoclonal antibody-based sandwich direct ELISA (MSD-ELISA) for antigen detection of foot-and-mouth disease virus using clinical samples. PLoS One. 9, e94143. https://doi.org/10.1371/journal.pone.0094143 (2014).

   Google Scholar 

2. Pal, P. et al. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog. 9, e1003312. https://doi.org/10.1371/journal.ppat.1003312 (2013).

   Google Scholar 

3. Keizer, R. J., Huitema, A. D. R., Schellens, J. H. M. & Beijnen, J. H. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin. Pharmacokinet. 49, 493–507. https://doi.org/10.2165/11531280-000000000-00000 (2010).

   Google Scholar 

4. Flessner, M. F. & Dedrick, R. L. Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodies. J. Controlled Release. 53, 69–75. https://doi.org/10.1016/S0168-3659(97)00238-1 (1998).

   Google Scholar 

5. Samaranayake, H., Wirth, T., Schenkwein, D., Raty, J. K. & Yla-Herttuala, S. Challenges in monoclonal antibody-based therapies. Ann. Med. 41, 322–331. https://doi.org/10.1080/07853890802698842 (2009).

   Google Scholar 

6. Harmsen, M. M. & De Haard, H. J. Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13–22. https://doi.org/10.1007/s00253-007-1142-2 (2007).

   Google Scholar 

7. Mashayekhi, V., Xenaki, K. T., van Bergen En Henegouwen, P. M. P. & Oliveira, S. Dual targeting of endothelial and cancer cells potentiates in vitro nanobody-targeted photodynamic therapy. Cancers (Basel). https://doi.org/10.3390/cancers12102732 (2020).

   Google Scholar 

8. Garaicoechea, L. et al. Llama-derived single-chain antibody fragments directed to rotavirus vp6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J. Virol. 82, 9753–9764. https://doi.org/10.1128/jvi.00436-08 (2008).

   Google Scholar 

9. Aksu, M. et al. Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral Res. 221, 105778. https://doi.org/10.1016/j.antiviral.2023.105778 (2024).

   Google Scholar 

10. Zhao, J. et al. A simple nanobody-based competitive ELISA to detect antibodies against African swine fever virus. Virol. Sin. 37, 922–933. https://doi.org/10.1016/j.virs.2022.09.004 (2022).

    Google Scholar 

11. Vega, C. G. et al. The first nanobody-based immunoassay to detect Group A Rotavirus. J. Virol. Methods. 298, 114279. https://doi.org/10.1016/j.jviromet.2021.114279 (2021).

    Google Scholar 

12. Wang, X. et al. A lateral flow immunochromatographic assay based on nanobody-oriented coupling strategy for aflatoxin B1 detection. Sens. Actuators B. 394, 134419. https://doi.org/10.1016/j.snb.2023.134419 (2023).

    Google Scholar 

13. Bai, M. et al. Nanobody-based immunomagnetic separation platform for rapid isolation and detection of Salmonella enteritidis in food samples. Food Chem. 424, 136416. https://doi.org/10.1016/j.foodchem.2023.136416 (2023).

    Google Scholar 

14. Rodríguez-Camejo, C. et al. A highly sensitive nanobody-based ELISA for bovine β-lactoglobulin to classified donated human milk destined to susceptible newborns. Food Control. 153, 109910. https://doi.org/10.1016/j.foodcont.2023.109910 (2023).

    Google Scholar 

15. McMahon, C. et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat. Struct. Mol. Biol. 25, 289–296. https://doi.org/10.1038/s41594-018-0028-6 (2018).

    Google Scholar 

16. Waraho, D. & DeLisa, M. Versatile selection technology for intracellular protein–protein interactions mediated by a unique bacterial hitchhiker transport mechanism. Proc. Natl. Acad. Sci. 106, 3692–3697. https://doi.org/10.1073/pnas.0704048106 (2009).

    Google Scholar 

17. Waraho-Zhmayev, D., Meksiriporn, B., Portnoff, A. D. & DeLisa, M. P. Optimizing recombinant antibodies for intracellular function using hitchhiker-mediated survival selection. Protein Eng. Des. Sel. 27, 351–358. https://doi.org/10.1093/protein/gzu038 (2014).

    Google Scholar 

18. Thaiprayoon, A. et al. Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy. Sci. Rep. 15, 3594. https://doi.org/10.1038/s41598-025-88032-1 (2025).

    Google Scholar 

19. Lebozec, K., Jandrot-Perrus, M., Avenard, G., Favre-Bulle, O. & Billiald, P. Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development. New Biotechnol. 44, 31–40. https://doi.org/10.1016/j.nbt.2018.04.006 (2018).

    Google Scholar 

20. Schiestl, M. et al. Acceptable changes in quality attributes of glycosylated biopharmaceuticals. Nat. Biotechnol. 29, 310–312. https://doi.org/10.1038/nbt.1839 (2011).

    Google Scholar 

21. Vermasvuori, R. Production of recombinant proteins and monoclonal antibodies: Techno-economical evaluation of the production methods Master thesis, Helsinki University of Technology, (2009).

22. Gonzalo-Asensio, J., Aguilo, N., Marinova, D. & Martin, C. Breaking transmission with vaccines: The case of tuberculosis. Microbiol. Spectr. 5, 101128 (2017).

    Google Scholar 

23. Singhla, T., Boonyayatra, S. & Prevalence Risk Factors, and Diagnostic Efficacy of Bovine Tuberculosis in Slaughtered Animals at the Chiang Mai Municipal Abattoir, Thailand. Front. Vet. Sci. 9, 846423. https://doi.org/10.3389/fvets.2022.846423 (2022).

    Google Scholar 

24. Torres-Gonzalez, P. et al. Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015. BMC Infect. Dis. 16, 657. https://doi.org/10.1186/s12879-016-2001-5 (2016).

    Google Scholar 

25. Romha, G., Gebru, G., Asefa, A. & Mamo, G. Epidemiology of Mycobacterium bovis and Mycobacterium tuberculosis in animals: Transmission dynamics and control challenges of zoonotic TB in Ethiopia. Prev. Vet. Med. 158, 1–17. https://doi.org/10.1016/j.prevetmed.2018.06.012 (2018).

    Google Scholar 

26. Krajewska-Wedzina, M. et al. Mycobacterium bovis transmission between cattle and a farmer in Central Poland. Pathogens https://doi.org/10.3390/pathogens11101170 (2022).

27. Hlokwe, T. M., van Helden, P. & Michel, A. L. Evidence of increasing intra and inter-species transmission of Mycobacterium bovis in South Africa: are we losing the battle? Prev. Vet. Med. 115, 10–17. https://doi.org/10.1016/j.prevetmed.2014.03.011 (2014).

    Google Scholar 

28. de la Rua-Domenech, R. Human Mycobacterium bovis infection in the United Kingdom: Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis 86, 77–109. https://doi.org/10.1016/j.tube.2005.05.002 (2006).

    Google Scholar 

29. Baker, M. G., Lopez, L. D., Cannon, M. C., De Lisle, G. W. & Collins, D. M. Continuing Mycobacterium bovis transmission from animals to humans in New Zealand. Epidemiol. Infect. 134, 1068–1073. https://doi.org/10.1017/S0950268806005930 (2006).

    Google Scholar 

30. Konate, M., Fofana, A., Haro, A., Ouattara, A. S. & Sanou, A. Socio-economic impact evaluation of bovine tuberculosis on primary meat production at the bobo-dioulasso slaughterhouse in burkina faso. Health 16, 1057–1067. https://doi.org/10.4236/health.2024.1611073 (2024).

    Google Scholar 

31. Smith, K., Kleynhans, L., Warren, R. M., Goosen, W. J. & Miller, M. A. Cell-mediated immunological biomarkers and their diagnostic application in livestock and wildlife infected with mycobacterium bovis. Front. Immunol. 12, 639605. https://doi.org/10.3389/fimmu.2021.639605 (2021).

    Google Scholar 

32. Wood, P. R. & Jones, S. L. BOVIGAM: An in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis 81, 147–155. https://doi.org/10.1054/tube.2000.0272 (2001).

    Google Scholar 

33. Gormley, E., Doyle, M. B., Fitzsimons, T., McGill, K. & Collins, J. D. Diagnosis of Mycobacterium bovis infection in cattle by use of the gamma-interferon (Bovigam) assay. Vet. Microbiol. 112, 171–179. https://doi.org/10.1016/j.vetmic.2005.11.029 (2006).

    Google Scholar 

34. Harvey, E. P. et al. An in silico method to assess antibody fragment polyreactivity. Nat. Commun. 13, 7554. https://doi.org/10.1038/s41467-022-35276-4 (2022).

    Google Scholar 

35. Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177, 4121–4130. https://doi.org/10.1128/jb.177.14.4121-4130.1995 (1995).

    Google Scholar 

36. Lynch, S. M., Zhou, C., Fau – Messer, A. & Messer, A. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. J. Mol. Biol. 377, 136–147. https://doi.org/10.1016/j.jmb.2007.11.096 (2008).

    Google Scholar 

37. Intasurat, K. et al. Redirecting a broad-spectrum nanobody against the receptor-binding domain of SARS-CoV-2 to target omicron variants. Appl. Sci. https://doi.org/10.3390/app142210548 (2024).

    Google Scholar 

38. Kasemsukwimol, W. et al. In The International Joint Conference on Environmental Engineering and Biotechnology (CoEEB 2023). (2023).

39. Submunkongtawee, N., Kamthong, A. & Waraho-Zhmayev, D. In 12th International Conference on Biomedical Engineering and Technology (ICBET) (ICBET 2022).

40. Kamthong, A., Poo-arporn, P. & Waraho-Zhmayev, R. D. In 6th International Conference on Agricultural and Biological Sciences (ABS). (2020).

41. Waraho, D. & DeLisa, M. P. Identifying and optimizing intracellular protein-protein interactions using bacterial genetic selection. Methods Mol. Biol. 813, 125–143. https://doi.org/10.1007/978-1-61779-412-4_7 (2012).

    Google Scholar 

42. Wilke, M. S., Lovering, A. L. & Strynadka, N. C. Beta-lactam antibiotic resistance: a current structural perspective. Curr. Opin. Microbiol. 8, 525–533. https://doi.org/10.1016/j.mib.2005.08.016 (2005).

    Google Scholar 

43. Matsumura, I. Why Johnny can’t clone: Common pitfalls and not so common solutions. Biotechniques 10, 2144000114324 https://doi.org/10.2144/000114324 (2015).

    Google Scholar 

44. Sehn, J. K. Insertions and Deletions (Indels). In: (eds Kulkarni, S. & Pfeifer, J.) Clinical Genomics. Academic, 129-150 (2015). https://doi.org/10.1016/B978-0-12-404748-8.00009-5

45. Doucet, J., Zhao, A., Fu, J. & Avrameas, A. Development and validation of an ELISA at acidic pH for the quantitative determination of IL-13 in human plasma and serum. Dis. Markers. 35, 465–474. https://doi.org/10.1155/2013/290670 (2013).

    Google Scholar 

46. Devanaboyina, S. C. et al. The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics. MAbs 5, 851–859. (2013). https://doi.org/10.4161/mabs.26389

    Google Scholar 

47. Patel, S. & Matthews, D. Humanised anti-IL17BR antibody. WO Patent 2020/115319 (2020).

48. Zahradnik, J. et al. A protein-engineered, enhanced yeast display platform for rapid evolution of challenging targets. ACS Synth. Biol. 10, 3445–3460. https://doi.org/10.1021/acssynbio.1c00395 (2021).

    Google Scholar 

49. Jaroszewicz, W., Morcinek-Orlowska, J., Pierzynowska, K., Gaffke, L. & Wegrzyn, G. Phage display and other peptide display technologies. FEMS Microbiol. Rev. https://doi.org/10.1093/femsre/fuab052 (2022).

    Google Scholar 

Download references

Authors and Affiliations

1. Biological Engineering Program, Faculty of Engineering, King Mongkut’s University of Technology Thonburi, Bangkok, 10140, Thailand

   Suwitchaya Sirimanakul, Apisitt Thaiprayoon, Kwanpet Intasurat, Warisara Kasemsukwimol, Nonth Submunkongtawee & Dujduan Waraho-Zhmayev

2. Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA

   Joseph D. Hurley & Andrew C. Kruse

3. Department of Biotechnology, Faculty of Applied Science, King Mongkut’s University of Technology North Bangkok, Bangkok, 10800, Thailand

   Lueacha Tabtimmai

4. Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand

   Kittitat Jaengwang & Kiattawee Choowongkomon

5. National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand

   Pinpunya Riangrungroj

6. National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand

   Jeerapond Leelawattanachai

7. Department of Livestock Development, National Institute of Animal Health, Bangkok, 10900, Thailand

   Kreeson Packthongsuk

Contributions

Conceptualization: K.P., D.W.-Z.; Methodology: S.S., J.D.H., A.T., K.I., W.K., N.S., P.R., J.L. K.P., D.W.-Z.;Investigation: S.S., J.D.H., A.T., K.P.; Formal analysis: S.S., J.D.H., L.T., K.J., K.P., D.W.-Z.; Software: S.S., J.D.H., L.T., K.J., K.C.; Data curation: S.S., J.D.H., K.J.; Visualization: S.S.; Supervision: D.W.-Z.; Project administration: K.P., D.W.-Z.; Resources: L.T., K.C., P.R., A.C.K., K.P., D.W.-Z.; Funding acquisition: S.S., D.W.-Z., K.P., A.C.K.; Writing—original draft preparation: S.S., J.D.H., A.C.K., D.W.-Z.; Writing—review and editing: S.S., L.T., K.C., P.R., J.L., K.P., D.W.-Z.

Corresponding author

Correspondence to Dujduan Waraho-Zhmayev.

Competing interests

A.C.K. is a cofounder and consultant for biotechnology companies Tectonic Therapeutic and Seismic Therapeutic, and also for the Institute for Protein Innovation, a nonprofit research institute. The other authors do not have any competing interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions